Pharma Journalist -

CSL Behring announced that it has agreed to acquire exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program, AMT-061 (etranacogene…
Read More...

Yumanity Therapeutics announced that it has entered into a strategic research collaboration and license agreement with Merck (known as MSD outside the United States and Canada) focused…
Read More...

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track designation to NeuroRx for the…
Read More...

Replicate Bioscience, Inc. and Immunomic Therapeutics, Inc. announced that the companies have entered into a research and licensing option agreement to combine their platform…
Read More...

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's…
Read More...

Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND)…
Read More...

Linnaeus Therapeutics, Inc. (Linnaeus) announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018…
Read More...

Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc., a privately held company developing…
Read More...

Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM). “We are pleased to welcome…
Read More...